Literature DB >> 26700157

JOURNAL CLUB: Evidence of Interstitial Lung Disease on Low-Dose Chest CT Images: Prevalence, Patterns, and Progression.

Mary Salvatore1, Claudia I Henschke1, Rowena Yip1, Adam Jacobi1, Corey Eber1, Maria Padilla1, Abraham Knoll1, David Yankelevitz1.   

Abstract

OBJECTIVE: The purposes of this study were to determine the prevalence of interstitial lung disease (ILD) in a cohort undergoing low-dose CT screening for lung cancer, to identify the CT patterns of fibrosis, and to determine prognostic factors of disease progression.
MATERIALS AND METHODS: The study drew from a database of 951 participants in a lung cancer screening program between 2010 and 2014. Three thoracic radiologists reviewed CT scans to identify the ILD findings, defined as traction bronchiectasis, ground-glass opacities with traction bronchiectasis, reticulations with traction bronchiectasis, and honeycombing. Evidence of ILD was considered present if at least two of three reviewing radiologists agreed. Age, smoking history, and CT evidence of emphysema were also documented.
RESULTS: Of the 951 participants, 63 (6.6%) had CT evidence of ILD, and 16 of the 63 (1.7% of the total cohort) had honeycombing. Significant univariate predictors of ILD were male sex (p = 0.003), older age (p < 0.0001), higher number of pack-years of cigarette smoking (p = 0.0003), and greater severity of emphysema (p = 0.004), but only age and male sex remained significant in the multivariate analysis. The most common pattern of ILD was peripheral fibrosis without honeycombing involving multiple lobes. The presence of honeycombing was significantly associated with progression of fibrosis score (p = 0.0001) and extent of fibrosis (p = 0.005).
CONCLUSION: A potential added benefit of CT screening is earlier diagnosis of ILD in older smokers, who are at increased risk. Radiologists should recognize the earliest findings of ILD and understand the importance of early recognition.

Entities:  

Keywords:  CT; honeycombing; interstitial lung disease; lung cancer

Mesh:

Year:  2015        PMID: 26700157     DOI: 10.2214/AJR.15.15537

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

1.  Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography.

Authors:  Justin M Oldham; Ayodeji Adegunsoye; Satinderpal Khera; Elyse Lafond; Imre Noth; Mary E Strek; Michael Kadoch; Jonathan H Chung
Journal:  Ann Am Thorac Soc       Date:  2018-06

Review 2.  Risk factors assessment and risk prediction models in lung cancer screening candidates.

Authors:  Mariusz Adamek; Ewa Wachuła; Sylwia Szabłowska-Siwik; Agnieszka Boratyn-Nowicka; Damian Czyżewski
Journal:  Ann Transl Med       Date:  2016-04

Review 3.  The importance of the regimen of screening in maximizing the benefit and minimizing the harms.

Authors:  Claudia I Henschke; Kunwei Li; Rowena Yip; Mary Salvatore; David F Yankelevitz
Journal:  Ann Transl Med       Date:  2016-04

4.  Interstitial lung abnormality is prevalent and associated with worse outcome in patients undergoing transcatheter aortic valve replacement.

Authors:  Michael Kadoch; Aleksandar Kitich; Shehabaldin Alqalyoobi; Elyse Lafond; Elena Foster; Maya Juarez; Cesar Mendez; Thomas W Smith; Garrett Wong; Walter D Boyd; Jeffrey Southard; Justin M Oldham
Journal:  Respir Med       Date:  2018-02-27       Impact factor: 3.415

Review 5.  Added benefits of early detection of other diseases on low-dose CT screening.

Authors:  Rowena Yip; Artit Jirapatnakul; Minxia Hu; Xiangmeng Chen; Dan Han; Teng Ma; Yeqing Zhu; Mary M Salvatore; Laurie R Margolies; David F Yankelevitz; Claudia I Henschke
Journal:  Transl Lung Cancer Res       Date:  2021-02

Review 6.  The Role of Radiology in Progressive Fibrosing Interstitial Lung Disease.

Authors:  Ahmad Abu Qubo; K M Capaccione; Elana J Bernstein; Maria Padilla; Mary Salvatore
Journal:  Front Med (Lausanne)       Date:  2022-01-13

7.  Chest computed tomography features of heart failure: A prospective observational study in patients with acute dyspnea.

Authors:  Kristina Miger; Andreas Fabricius-Bjerre; Anne Sophie Overgaard Olesen; Ahmad Sajadieh; Nis Høst; Nanna Køber; Annemette Abild; Mathilde Marie Winkler Wille; Jesper Wamberg; Lars Pedersen; Hans Henrik Lawaetz Schultz; Christian Torp-Pedersen; Olav Wendelboe Nielsen
Journal:  Cardiol J       Date:  2022-02-11       Impact factor: 2.737

8.  Interstitial Lung Disease Associated with Lung Cancer: A Case-Control Study.

Authors:  Quentin Gibiot; Isabelle Monnet; Pierre Levy; Anne-Laure Brun; Martine Antoine; Christos Chouaïd; Jacques Cadranel; Jean-Marc Naccache
Journal:  J Clin Med       Date:  2020-03-05       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.